A biotech hedge fund births a new immunology company
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"A biotech hedge fund births a new immunology company" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include TechStock², stocktitan.net, Fierce Biotech and Yahoo Finance. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 60d ago.
Quick answers
Why is "A biotech hedge fund births a new immunology company" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Halper Sadeh LLC is Investigating Whether AEMD, CSR, ATKR are Obtaining Fair Deals for their Shareholders GlobeNewswire · 61d ago
- A merger could put $180 million behind a new eczema treatment Stock Titan · 61d ago
- Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger Yahoo Finance · 61d ago
- Client and Medical Therapeutic Company Aethlon Medical Announces Merger With North Immunology Procopio · 61d ago
- Aethlon Medical, Inc. (NASDAQ:AEMD) To Merge With North Immunology; $180M Financing TradingView · 61d ago
- Aethlon’s 467% Stock Rally Reflects a $16.5 Million Merger Stub, Not a $346.5 Million Windfall TechStock² · 61d ago
- Haymaker Acquisition Corp V SEC Filing (Sep 17, 2026) stocktitan.net · 61d ago
- North Immunology goes public via reverse merger as eczema drug heads toward clinic Fierce Biotech · 61d ago
- Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis Yahoo Finance · 61d ago
- A biotech hedge fund births a new immunology company STAT · 61d ago
Topics
Related trends
Diamondback nears $5 billion deal to buy drilling portfolio from Double Eagle, FT says
Diamondback Energy agreed to buy Double Eagle subsidiaries for about 15.56 million shares and $2.15 billion cash, valuing the deal at roughly $5 billion, with closing expected December 21, 2026.
Gen Z judges colleagues who use AI, but paradoxically may see it as the key to their own promotion
New survey coverage reveals a stark generational paradox as younger workers harbor deep concerns over artificial intelligence while eyeing promotion pathways.
$25,000 county grant aims to keep Twin Trees restaurant on Avery Avenue open
A Syracuse institution reopens after a county grant reverses a permanent closure.
Eric Trump-backed robot soldier startup can't pay staff after founder borrowed $4.6 million from company to buy home
An Eric Trump-backed robot soldier startup misses payroll after its founder reportedly borrows millions for a home.
Disney beats fourth-quarter estimates, targets $3 billion in savings through cost-cutting efforts
Disney reports fourth-quarter earnings beating estimates alongside a new target for billions in savings.
China’s ‘miracle city’ that no US president has visited (yet)
Coverage highlights Shenzhen as a leading economic force, noted for a lack of visits by any US president.